EPO’s new examination guidelines: what you need to know

A new edition of the European Patent Office (EPO) Guidelines for Examination came into force on March 1, 2021. Relevant to life sciences, this edition includes a new subsection detailing EPO practice with respect to the interpretation of terms relating to amino or nucleic acid sequences, as well as a new section on the examination of claims to antibodies.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech

Europe’s missing biotech bridge: Why IP ownership matters more than capital access

17 August 2026 Europe’s biotechnology challenge is not only whether it can fund innovation. It is whether it can continue to originate and control the foundational IP positions from which future biotech value is created. Paul Calvo of Sterne Kessler explains.

Biotech

Masimo keeps $634m smartwatch award and moves to appeal

21 July 2026 Now a Danaher subsidiary, the company is contesting a number of orders after a California court finalised several aspects of the high-profile dispute.

Biotech

Arbutus takes Comirnaty LNP patent fight to Canada and UPC

20 July 2026 The biotech company has launched a trio of lawsuits against two vaccine makers, while announcing receipt of a $178 million sum from Moderna under a previous deal.

More features

Europe’s missing biotech bridge: Why IP ownership matters more than capital access

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

The UPC plugs another gap in its procedural rulebook

Patent litigator joins Baker Botts in London as UPC grows in significance

USPTO director steps into Sun Pharma’s PTAB-ITC clash

European court strikes down hearing aid sensor patent

Where Big Pharma is betting big in the M&A boom

EPO’s new examination guidelines: what you need to know

More on this story

Editor's picks

Editor's picks

More features